Glenmede Trust CO Na Maravai Lifesciences Holdings, Inc. Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

A detailed history of Glenmede Trust CO Na transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 2,226,034 shares of MRVI stock, worth $11.6 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

2,226,034

Previous 2,257,887 1.41%

Holding current value

$11.6 Million

Previous $16.2 Million 14.43%

% of portfolio

0.09%

Previous 0.08%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$6.84 - $9.73 $217,874 - $309,929	-31,853 Reduced 1.41%	2,226,034 $18.5 Million
Q2 2024 Aug 14, 2024	BUY	$6.87 - $11.34 $93,926 - $155,040	13,672 Added 0.61%	2,257,887 $16.2 Million
Q1 2024 May 15, 2024	BUY	$5.11 - $8.76 $824,176 - $1.41 Million	161,287 Added 7.74%	2,244,215 $19.5 Million
Q4 2023 Feb 13, 2024	BUY	$4.7 - $9.87 $4.58 Million - $9.62 Million	974,374 Added 87.9%	2,082,928 $13.6 Million
Q3 2023 Nov 14, 2023	BUY	$9.14 - $12.85 $6.29 Million - $8.85 Million	688,403 Added 163.85%	1,108,554 $11.1 Million
Q2 2023 Aug 14, 2023	BUY	$12.09 - $15.0 $298,816 - $370,740	24,716 Added 6.25%	420,151 $5.22 Million
Q1 2023 May 15, 2023	BUY	$12.99 - $16.48 $4.81 Million - $6.1 Million	369,903 Added 1448.78%	395,435 $5.54 Million
Q4 2022 Feb 14, 2023	BUY	$12.5 - $24.78 $149,175 - $295,724	11,934 Added 87.76%	25,532 $365,000
Q3 2022 Nov 16, 2022	SELL	$20.6 - $30.37 $502,145 - $740,299	-24,376 Reduced 64.19%	13,598 $347,000
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $989,222 - $1.42 Million	37,974 New	37,974 $1.08 Million

Others Institutions Holding MRVI

# of Institutions

233

Shares Held

141M

Call Options Held

223K

Put Options Held

19.4K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $684M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Maravai Lifesciences Holdings, Inc. Transaction History